References
- Bidet P, Lalande V, Salauze B, et al. Comparison of PCR-Ribotyping, Arbitrarily PCR and Pulse-Field Gel Electrophoresis for Typing Clostridium difficile // J Clin Microbiol, 2000; 38:2484-2487
- Biller P, Shank B, Lind L, et al. Moxifloxacin Therapy as a Risk Factor for Clostridium difficile-Associated Disease During an Outbreak: Attempts to Control a New Epidemic Strain // Infect Control Hosp Epidemiol, 2007; 28:199-201
- Bouza E, Burillo A, Munoz P. Antimicrobial Therapy of Clostridium difficile-Associated Diarrhea // Med Clin North America, 2006; 90:1141-1163
- Chandler R E, Hedberg K, Cieslak R. Clostridium difficile-Associated Disease in Oregon: Increasing Incidence and Hospital-level Risk factor // Infect Control Hosp Epidemiol, 2007; 28:116-122
- Clifford L, Coignard B. Recommendations for Surveilance of Clostridium difficile-Associated Disease // Infect Control Hosp Epidemiol, 2007; 28: 140-145
- Coignard B, Barbut F, Blanckaert K, et al. Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease // Euro Surveill, 2006; 11: pii=060914
- Daniel E, Ballard D. Clostridium difficile Toxins: Mechanism of Action and Role in Disease // CMR, 2005; 18:247-263
- Delme M, Ramboer I, Van Broeck I, et al. Epidemiology of Clostridium difficile toxinotype III, PCR-ribotype 027 associated disease in Belgium // Euro Surveill, 2006; 11:3045
- Gerding N, Johnson S, Peterson R, et al. Clostridium difficile-associated diarrhea and colitis // Infect Control Hosp Epidemiol, 1995; 16:459-477
- Indra A, Huhulescu S, Hasenberger P, et al. First isolation of Cl. difficile PCR ribotype 027 in Austria // Euro Surveill, 2006; 11:pii=3046
- Kelly P, Pothoulakis C, LaMont T. Clostridium difficile colitis // NEJM, 1991; 330:257-262
- Killgore G, Thompson A, Johnson S, et al. Comparision of Seven Technigues for Typing International Epidemic Strains of Clostridium difficile: REA, PFGE, PCR-ribotyping, MLST, MLVA, AFLP, and slpAST // J Clin Microbiol, 2008; 46: 432-437
- Kuijper J, Coignard B, Tüll P. Emergence of Clostridium difficile-associated disease in North America and Europe // CMI, 2006; 12:2-18
- Kuijper J, Surawicz M. Clostridium difficile infection // Lancet, 2008; 371:1486-1488
- Lemee L, Bourgeois I, Ruffin E, et al. Multilocus sequence analysis and comparative evolution of virulence-associated genes and housekiping genes of Clostridium difficile // J Clin Microbiol, 2005; 46:3171-3180
- Lemee L, Dhalluin A, Pestel-Caron M, et al. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types // J Clin Microbiol, 2004; 28: 2609-1617
- Long S, Fenebon L, Fitzgerald S, et al. First isolation and report of cluusters of C.difficile PCR 027 cases in Ireland // Euro Surveill, 2007; 12:pii=3183
- Pepin J, Valquette L, Alary E, et al. Clostridium difficile-Associated diarrhea in a region of Quebec from 1991 to 2003: a cahgning pattern of disease severity // CMAJ, 2004; 171:466-472
- Pepin J, Valiguette L, Cossete B. Mortality attributall to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec // CMAJ, 2005; 170:1037-1042
- Poxton R, McCouberey J, Blair G. The pathogenicity of Clostridium difficile // Clin Microbiol Infect, 2001; 7:421-427
- Rupnik M, Aveseni V, Janc M, et al. Toxinotyping Schema and Correlation of Toxinotypes with Serogroups of Clostridium difficile Isolates // J Clin Microbiol, 1998; 23:2240-2247
- Soes L, Mollak K, Trobek S, et al. The emergence of Cl. difficile PCR Ribotype 027 in Denmark // Euro Surveill, 2009; 14:19183
- Tachon M, Cattone C, K. Balanckaert, et al. First cluster of Clostridium.difficile toxinotype III, PCR-ribotype 27 associated disease in France: prelimunary report // Euro Surveill, 2006; 11:2951